These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 16188972)
1. Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells. Jones KS; Petrow-Sadowski C; Bertolette DC; Huang Y; Ruscetti FW J Virol; 2005 Oct; 79(20):12692-702. PubMed ID: 16188972 [TBL] [Abstract][Full Text] [Related]
2. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. Jones KS; Fugo K; Petrow-Sadowski C; Huang Y; Bertolette DC; Lisinski I; Cushman SW; Jacobson S; Ruscetti FW J Virol; 2006 Sep; 80(17):8291-302. PubMed ID: 16912281 [TBL] [Abstract][Full Text] [Related]
3. The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2. Jones KS; Huang YK; Chevalier SA; Afonso PV; Petrow-Sadowski C; Bertolette DC; Gessain A; Ruscetti FW; Mahieux R J Virol; 2009 May; 83(10):5244-55. PubMed ID: 19279090 [TBL] [Abstract][Full Text] [Related]
5. DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells. Jain P; Manuel SL; Khan ZK; Ahuja J; Quann K; Wigdahl B J Virol; 2009 Nov; 83(21):10908-21. PubMed ID: 19692463 [TBL] [Abstract][Full Text] [Related]
6. Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta. Jones KS; Akel S; Petrow-Sadowski C; Huang Y; Bertolette DC; Ruscetti FW J Immunol; 2005 Apr; 174(7):4262-70. PubMed ID: 15778389 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of chondroitin sulfate type E on the binding step of human T-cell leukemia virus type 1. Jinno-Oue A; Tanaka A; Shimizu N; Mori T; Sugiura N; Kimata K; Isomura H; Hoshino H AIDS Res Hum Retroviruses; 2013 Mar; 29(3):621-9. PubMed ID: 23033806 [TBL] [Abstract][Full Text] [Related]
8. HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165. Lambert S; Bouttier M; Vassy R; Seigneuret M; Petrow-Sadowski C; Janvier S; Heveker N; Ruscetti FW; Perret G; Jones KS; Pique C Blood; 2009 May; 113(21):5176-85. PubMed ID: 19270265 [TBL] [Abstract][Full Text] [Related]
9. Similar regulation of cell surface human T-cell leukemia virus type 1 (HTLV-1) surface binding proteins in cells highly and poorly transduced by HTLV-1-pseudotyped virions. Jones KS; Nath M; Petrow-Sadowski C; Baines AC; Dambach M; Huang Y; Ruscetti FW J Virol; 2002 Dec; 76(24):12723-34. PubMed ID: 12438598 [TBL] [Abstract][Full Text] [Related]
10. GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1. Takenouchi N; Jones KS; Lisinski I; Fugo K; Yao K; Cushman SW; Ruscetti FW; Jacobson S J Virol; 2007 Feb; 81(3):1506-10. PubMed ID: 17108050 [TBL] [Abstract][Full Text] [Related]
11. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I. Moriuchi H; Moriuchi M Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373 [TBL] [Abstract][Full Text] [Related]
12. Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Jones KS; Petrow-Sadowski C; Huang YK; Bertolette DC; Ruscetti FW Nat Med; 2008 Apr; 14(4):429-36. PubMed ID: 18376405 [TBL] [Abstract][Full Text] [Related]
13. Regulation of the cell-surface expression of an HTLV-I binding protein in human T cells during immune activation. Nath MD; Ruscetti FW; Petrow-Sadowski C; Jones KS Blood; 2003 Apr; 101(8):3085-92. PubMed ID: 12506039 [TBL] [Abstract][Full Text] [Related]
14. Evasion of a Human Cytomegalovirus Entry Inhibitor with Potent Cysteine Reactivity Is Concomitant with the Utilization of a Heparan Sulfate Proteoglycan-Independent Route of Entry. Murray MJ; Bonilla-Medrano NI; Lee QL; Oxenford SJ; Angell R; Depledge DP; Reeves MB J Virol; 2020 Mar; 94(7):. PubMed ID: 31941787 [TBL] [Abstract][Full Text] [Related]
15. Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells. Kinet S; Swainson L; Lavanya M; Mongellaz C; Montel-Hagen A; Craveiro M; Manel N; Battini JL; Sitbon M; Taylor N Retrovirology; 2007 May; 4():31. PubMed ID: 17504522 [TBL] [Abstract][Full Text] [Related]
16. Cellular Factors Involved in HTLV-1 Entry and Pathogenicit. Hoshino H Front Microbiol; 2012; 3():222. PubMed ID: 22737146 [TBL] [Abstract][Full Text] [Related]
17. Current concepts regarding the HTLV-1 receptor complex. Ghez D; Lepelletier Y; Jones KS; Pique C; Hermine O Retrovirology; 2010 Nov; 7():99. PubMed ID: 21114861 [TBL] [Abstract][Full Text] [Related]
18. Cell-Free versus Cell-to-Cell Infection by Human Immunodeficiency Virus Type 1 and Human T-Lymphotropic Virus Type 1: Exploring the Link among Viral Source, Viral Trafficking, and Viral Replication. Dutartre H; Clavière M; Journo C; Mahieux R J Virol; 2016 Sep; 90(17):7607-17. PubMed ID: 27334587 [TBL] [Abstract][Full Text] [Related]
19. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells. Banerjee P; Feuer G; Barker E J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265 [TBL] [Abstract][Full Text] [Related]
20. Neuraminidase enhances the initial steps of human T-cell leukemia virus type 1 replication. Tanaka M; Sun B; Tezuka K; Fujisawa J; Tanaka Y; Hoshino H; Miwa M Microbes Infect; 2010 Feb; 12(2):119-25. PubMed ID: 19892032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]